An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
Clinical trial NCT06335979 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06335979
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2027-11-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.